Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
09/2002
09/03/2002US6444811 Central nervous system disorders; cardiovascular disorders
09/03/2002US6444226 Purification and stabilization of peptide and protein pharmaceutical agents
08/2002
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002030930A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120137 FXR modulators
08/29/2002US20020119961 Bridged piperazine derivatives
08/29/2002US20020119910 Drug delivery
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1234827A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234826A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234825A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234824A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234823A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002CN1365974A Process for preparing 5-methylpyrazine-2-carboxylic acid from KMnO4 by one-step oxidizing method
08/27/2002US6441172 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6440618 Imaging element containing a blocked photographically useful compound
08/22/2002WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064140A1 Thrombin inhibitors
08/22/2002US20020115859 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials
08/22/2002US20020115853 6-(3-nitrophenyl)-3H-benzooxazol-2-one for example; contraceptives, treating hormone dependent tumors, endometriosis; progesterone receptor agonists and antagonists
08/22/2002US20020114056 Electrochromic device having improved light stability
08/22/2002CA2436068A1 Thrombin inhibitors
08/22/2002CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/21/2002CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
08/21/2002CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same
08/15/2002WO2002062761A1 Aminal diones as potassium channel openers
08/15/2002WO2002062423A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
08/15/2002US20020111335 Bactericides, bacteriostats
08/15/2002US20020111273 Insecticides, fungicides, miticides, plant safening agents
08/15/2002CA2437400A1 Aminal diones as potassium channel openers
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/13/2002US6432962 Antiinflammatory agents
08/13/2002US6432949 Amide derivatives useful as inhibitors of the production of cytokines
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/08/2002WO2002060492A1 Methods of inhibiting kinases
08/08/2002WO2002018327A3 Guanidinobenzamides as mc4-r agonists
08/08/2002WO2002000631A3 Benzhydryl derivatives
08/08/2002US20020107406 Calcium receptor-active compounds
08/08/2002US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
08/08/2002CA2436487A1 Methods of inhibiting kinases
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP0770599B1 Process for the preparation of aromatic or heteroaromatic sulfonyl halides
08/07/2002EP0705824B1 Process for producing optically active n-tert-butyl- 2-piperazine- carboxamide
08/07/2002CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments
08/06/2002US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/01/2002WO2002059127A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002US20020103379 Making 2,2-difluoro-2-(2-pyridyl)-ethan-1-ol, by coupling 2-bromopyridine with ethyl 2-bromo-2,2-difluoroacetate, using metallic copper and solvent; chemical intermediates
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103204 Piperazinyl)-3-(2-(3-(4-morpholinylmethyl)phenoxy)ethoxy) pyrazine derivatives; for prophylaxis or treatment of serotonin-related diseases
08/01/2002US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
08/01/2002US20020103191 Antitumor dibenzofluorene derivatives
08/01/2002US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
08/01/2002US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002CA2431970A1 Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists
07/2002
07/31/2002EP1226128A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
07/31/2002CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
07/31/2002CN1361687A Phosphate transport inhibitors
07/30/2002US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
07/30/2002US6426347 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
07/25/2002WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002057233A1 Mch antagonists and their use in the treatment of obesity
07/25/2002WO2002057230A1 Il-8 receptor antagonists
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002056827A2 Substituted felbamate derived compounds
07/25/2002WO2002032901A3 Bridged piperazine derivatives
07/25/2002WO2002002519A3 THROMBIN OR FACTOR Xa INHIBITORS
07/25/2002WO2001000654A9 Purification and stabilization of peptide and proteins in pharmaceutical agents
07/25/2002US20020099212 Sulfonamide compounds and pharmaceutical use thereof
07/25/2002US20020099050 E.g., 1-(1,4-benzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine), 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine); and 1-(1,3-benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine
07/25/2002DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases
07/25/2002CA2427058A1 Substituted felbamate derived compounds
07/24/2002EP1224165A1 Novel compounds
07/24/2002EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same
07/24/2002CN1360588A Hemisynthetic method and intermediate thereof
07/24/2002CN1360583A Novel compounds, their use and preparation
07/24/2002CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
07/24/2002CN1360570A Phenyl sulfamate derivs.
07/24/2002CN1360502A Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
07/23/2002US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2002US6423699 Contraceptives
07/18/2002WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/18/2002WO2001072728A3 Novel piperazine derivatives
07/18/2002US20020095056 Hydrogenation of an imine in the presence of a base and, a ruthenium complex of a chiral diphosphine and diamine catalyst
07/18/2002US20020095038 Novel method for the preparation of piperazine and its derivatives
07/18/2002CA2433084A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
07/17/2002CN1087735C Process for preparation of pesticidal 1-(haloaryl) heteroyclic compounds
07/16/2002US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents
07/16/2002US6420423 Pesticides